Patents Assigned to Therapeutical Systems Corporation
  • Cancer therapy system for effecting oncolysis of malignant neoplasms
    Patent number: 4935450
    Abstract: A method for effecting oncolysis, regression, and control of malignant neoplasms in humans and other mammals without adverse effects on normal body cells is described. An ATP-availability depressor may be combined with a defined nutritional regimen, a fatty acid blocker, an amino acid blocker, a lactate export blocker, or any combination thereof.
    Type: Grant
    Filed: August 22, 1988
    Date of Patent: June 19, 1990
    Assignee: Therapeutical Systems Corporation
    Inventor: Clarence D. Cone, Jr.